Popular Articles

American Cancer Society To Recognize Corporate Employers Changing The Course Of The Cancer Fight
The American Cancer Society - the nation"s leading voluntary health organization and largest non-governmental funder of cancer research and discovery - will present its Corporate Impact Awards June 19 during the Society-hosted Corporate Impact Conference in Chicago. The awards will recognize companies" engagement in targeted efforts to significantly impact cancer"s effect on the workplace, where disease-related expenditures and lost productivity costs annually surpass $228 billion; in contributing funds to the American Cancer Society to fight the disease; and in addressing responsible community involvement.
new payday loan lenders 3ds max model
Medicare Analysis Finds Too Many Needless Deaths At Hospitals
A new Medicare analysis by the Centers for Medicare and Medicaid Services found a "double failure" at U.S. hospitals. Its release comes as the White House and Congress seek ways to reward quality over quantity of care in health care reform. USA Today reports that "Too many people die needlessly at U.S. hospitals, according to a sweeping new Medicare analysis showing wide variation in death rates between the best hospitals and the worst. The analysis examined death rates for heart attacks, heart failure and pneumonia at more than 4,600 hospitals across the USA. At 5.9% of hospitals, patients with pneumonia died at rates significantly higher than the national average. With heart failure, 3.4% of hospitals had death rates higher than the average, and 1.2% of hospitals were higher when it came to heart attack. Researchers also found that the majority of U.S. hospitals operate the equivalent of revolving doors for their patients. One of every four heart failure patients and slightly less than one in five heart attack and pneumonia patients land back in the hospital within 30 days, data show."
Shop for Boon High Chair at Target.
News of the day
Nycomed Announces FDA Filing For Daxas(R) In COPD
Nycomed announced the submission of a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for Daxas® as a once-daily oral treatment for patients with symptomatic COPD. The NDA submission is based on encouraging results from four Phase III trials of Daxas® (roflumilast) in the treatment of symptomatic COPD. Two pivotal 12-month studies showed positive effects on exacerbation rates and pulmonary function (FEV1). Two supporting six-month studies also confirmed the efficacy of Daxas when used with standard bronchodilator treatments. Full data from all four studies are to be published during 2009.
Cardiovascular

Smoking, High Blood Pressure And Diabetes In Mid-life Can Lead To Dementia

Middle aged people who smoke, have high blood pressure or diabetes are far more likely to develop dementia in later life, suggests research published ahead of print in the Journal of Neurology, Neurosurgery and Psychiatry. People should consider modifying their lifestyle in mid-life to avoid developing dementia, claims the US research. Dementia is a growing public health problem affecting older people in developed countries. In the US, where the research took place, estimates show that one in six people older than 70 have dementia. Estimates are that the number of people with dementia will grow threefold by 2050, compared with 2000. Previous studies have shown that the presence of cardiovascular risk factors including high blood pressure, diabetes, obesity and smoking increase the risk of developing subsequent dementia, but have often failed to show the relationship. Researchers from the universities of Minnesota, North Carolina and John Hopkins and the University of Mississippi Medical Center studied more than 11,000 people aged 46-70 who were participants in the Atherosclerosis Risk in Communities (ARIC) study in 1990-92. People underwent a physical examination and cognitive testing at that time and they were followed up until 2004 to see how many were hospitalised with dementia. After following their progress, the researchers identified 203 cases of hospitalisation with dementia. Smoking, high blood pressure and diabetes were all strongly associated with dementia in white participants and African-Americans. The results showed that rates of hospitalisation with dementia increased exponentially with age in men and women and in different ethnic backgrounds. Overall, African-Americans had a two and a half times higher rate of hospitalisation than white people and African-American women in particular had the highest rates of all. Current smokers were 70% more likely than those who had never smoked to develop dementia, people with high blood pressure were 60% more likely than those without high blood pressure, and people with diabetes were more than twice as likely than those without diabetes to develop it. No association was found between people who were obese/overweight and dementia in later life. The authors say the results suggest that smoking cessation and prevention or control of high blood pressure and diabetes starting in midlife may have the added benefit of decreasing dementia hospitalisation risk. They conclude: "Our results emphasise the importance of early lifestyle modification and risk factor treatment to prevent dementia." "Risk of dementia hospitalisation associated with cardiovascular risk factors in midlife and older age: the Atherosclerosis Risk in Communities (ARIC) study." J Neurol Neurosurg Psychiatry2009; doi 10.1136/jnnp.2009.176818 Journal Of Neurology, Neurosurgery & Psychiatry


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):